Salivary Oxytocin as a Biomarker of Psychedelic Treatment
Salivary Oxytocin as a Biomarker of Psychedelic Treatment
Enrolling by invitation · NCT07345858 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Salivary Oxytocin as a Biomarker of Psychedelic Treatment | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Enrolling by invitation | Not stated | 2026-01-16 | NCT07345858 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Geneva, Switzerland | 42 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Geneva University Hospitals | Geneva | Switzerland | 8 |